Furthermore, McIlroy et al. [9] described that Ad-B2(−/−) mice, as well as Ad-B2(−/−) mice with additional ablation of hepatic Bscl2, did not develop hepatic steatosis [16]. Here, BSCL2 is linked to fatty liver disease.